Search

everythinglearnresearchcommunity

for

Search:↓

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Different light affects cell functions and can help treat skin conditions.

Vimentin and transthyretin proteins are linked to black coat color in sheep.

Using platelet growth factors can improve hair density in transplants, especially for those with fine hair.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Laser technologies improve medical treatments and outcomes.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

Human hair shafts inhibit Gram-positive bacteria growth but not Gram-negative bacteria.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

Low-dose naltrexone and platelet-rich plasma can regrow hair in lichen planopilaris.

Artificial hair implants can still cause side effects despite improvements.

COVID-19 may cause hair loss by affecting hair follicles.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

TrichoxidilTM could be a promising new treatment for hair loss.

Different hair types in mammals are linked to variations in specific protein genes, with changes influenced by their living environments.

Chemical hair straightening can damage hair and health, needing safer alternatives and stricter regulations.

An artificial lipid barrier can restore hair growth in cases of SCD1 deficiency.

Stopping imipramine reduced the woman's hair loss.